期刊文献+

同胞异基因造血干细胞移植治疗Ph+急性髓系白血病M4一例并文献复习 被引量:1

原文传递
导出
摘要 目的分析Ph染色体阳性的急性髓系白血病(AML)患者的临床特点,探讨其治疗方法。方法报道1例Ph+AML的形态学、免疫学、细胞遗传学及分子生物学特点,并行同胞异基因造血干细胞移植,同时对相关文献进行复习。结果该病例在移植后2年内无不良反应发生,骨髓穿刺均提示缓解。结论Ph+AML预后欠佳,异基因造血干细胞移植可能是其治疗有效方法之一。
出处 《白血病.淋巴瘤》 CAS 2011年第11期683-684,共2页 Journal of Leukemia & Lymphoma
基金 江苏省青年科技创新人才基金(BK2004424) 江苏省135重点学科开放基金(135XY0416) 苏州大学附属第一医院优秀青年骨干基金(2004YQG05) 江苏省卫生厅135重点人才基金(RC2002033)
  • 相关文献

参考文献9

  • 1张学进,杨玮,叶锦,陈志妹,邓,赵毅,孙静.Ph染色体阳性急性髓系白血病细胞免疫表型及临床特征研究[J].实用肿瘤杂志,2002,17(2):95-96. 被引量:1
  • 2Bloomfield CD, Lindquist LL, chromosome in acute leukemia. 1978, 29: 81-91.
  • 3Brunning RD. The Philadelphia Virehows Arch B Cell Pathology, Cuneo A, Ferrant A, Michanx JL, et al. Philadelphia chromosome- positive acute myeloid leukemia: "cytoimmunologic and cytogenetic features. Haematologica, 1996, 81: 423-427.
  • 4Paietta E, Racevskis J, Bennett JM, et al. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia, 1998, 12: 1881-1885.
  • 5Yamaguchi H, Inokuchi K, Yokomizo E, et al. Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy. Ihter J Hematol, 2002, 75: 63-66.
  • 6邱镜滢,朱伟,张艳,陈珊珊,江滨,史惠琳,师岩,何琦,党辉,王德炳,陆道培.Ph染色体阳性急性白血病细胞遗传学及临床研究[J].中国实验血液学杂志,2005,13(3):358-363. 被引量:15
  • 7Yoshida A, Kishi S, Kita K, et al. Philadelphia chromosome-positive Anticancer Res, 1997, 17: 625-628.
  • 8Molecular analysis of a case of acute myeloid leukemia. Yamaguchi M, Konishi I. Successful treatment with imatinib mesylate for Philadelphia chromosome-positive refractory acute myeloid leukemia. Japan J Clin Hematol, 2003, 44: 254-256.
  • 9Viniou NA, Vassilakopoulos TP, Giakoumi X, et al. Ida-FLAG plus imatinib mesylate-induced molecular remission in a patient with chemoresistant Ph 1 (+) acute myeloid leukemia. Eur J Hematol, 2004, 72: 58-60.

二级参考文献19

  • 1Weiss M, Maslak P, Feldman E, et al. Cytarabine with high-mitoxantrane induces rapid complete remission in adult acute lymphoblastic leukemia without the use of vincristine or prednisine. J Clin Oncol, 1996, 14, 2480-2485.
  • 2Dombret H, Gabert J, Boiron JM, et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia-results of the prospective multicenter LALA-94 trial.Blood, 2002, 100:2357 -2366.
  • 3Sierra J, Radich J, Hansen JA, et al. Bone marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia, Blood, 1997, 90: 1410-1444.
  • 4Snyder DS, Nademanee AP, O'Dormell MR, et al. Long-term follow -up of 23 patients with Philadelphia chromosome positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplantation in first complete remission. Leukemia, 1999, 13:2053- 2058.
  • 5Arico M, Valsecchi MG, Camitta B, et al. Outcome of treatment in children with Phaladelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med, 2000, 342:998 -1006.
  • 6Mori T, Manabe A, Tsuchida M, et al. Allogeneic bone marrow transplantation in fast remission rescue children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study (TCCSG) studies L89-12 and L92-13. Med Pediatx Oncol 2001 , 37:426 -431.
  • 7Preti HA,O′Berien S,Giralt S,et al. Philadelphia-chromoosome positive adult acute lymphoblastic leukemia: characteristic, treatment results and prognosis in 41 patients. Am J Med, 1994 ,97 : 60- 65.
  • 8Annino L, Ferrari A, Cedroine M, et al. Adult Philadelphia chromosome-positive acute lymphoblastic leukemia: experience of treatments during a ten-year period. Leukemia, 1994, 8:664 -667.
  • 9Paietta E, Racevskis J, Bennett JM, et al. Biology heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Easten Cooperative Oncology Group experience.Leukemia, 1998, 12:1881-1885.
  • 10Cigudosa JC, Acosta-Almeida MT, Catrasco V, et al. BCR-ABL rearrangement and variant Philadelphia chromosome in de novo acute myelogenous leukemia. Br J Heamatol, 1995, 91 : 931 -934.

共引文献14

同被引文献12

  • 1张之南,沈悌.血液病诊断及疗效标准.3版.北京:科学出版社,2011.
  • 2Savage DG, Antman KH. Imatinih mesylate-a new oral targeted therapy. N Engl J Med, 2002, 34: 683-693.
  • 3Brian J, Kantarjion HM, Talpaz M, et al. A phase I study of Gleevec (Imatinib Mesylae) administered concomitantly with cytosine arabinoside (Arz-C) in patients with Philadelphia positive chronic myeloid leukemia(CML). Blood, 200l, 98: 845a.
  • 4Yamamoto K, Nakamure Y, Arai H, et al. Triple philadelphia ehrnmosomes with major-her rean'angement in hyttripkdd erythroleukaemia. EurJ Haematol, 2000, 65: 182-187.
  • 5Cho BS, Kim HJ, Lee S, et al. Successful interim therapy with imatinib prior to allogeneie stem cell transplantation in Philadelphia chromosomo positive acute myeloid leukemia. Eur J Hematol, 2007, 79: 170-173.
  • 6Sun J, Wang Z, Luo Y, et al. Prolonged survival with imatinib mesylate combined with chemotherapy find allogeneic stem cell transplantation in de novo Ph* acute myeloid leukemia. Acta Haematol, 2012, 127: 143-148.
  • 7战榕,许贞书,李乃农,吴勇,陈志哲.伊马替尼联合其他化疗方案治疗Ph^+急性淋巴细胞白血病[J].白血病.淋巴瘤,2007,16(2):125-127. 被引量:1
  • 8肖志坚,卞寿庚,郝玉书,李建波,钱林生,阎嶂松,薛艳萍,赵耀中.Ph染色体阳性的成人急性髓系白血病[J].中华血液学杂志,1999,20(1):43-44. 被引量:3
  • 9岳志霞,李蓓,赵晓曦,刘怡,李彬.3例费城染色体阳性急性髓系白血病临床和实验室分析[J].中国小儿血液与肿瘤杂志,2011,16(4):182-185. 被引量:3
  • 10费新红,武淑兰,孙瑞娟,周葭蕤,王静波,王彤,刘红星,王卉,童春容,吴彤,陆道培.12例Ph染色体和BCR-ABL阳性急性髓系白血病临床分析[J].中国实验血液学杂志,2012,20(3):545-548. 被引量:14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部